Analyst firms · Wolfe Research · BRKR
Wolfe Research BRKR price target and rating history
Bruker Corporation (BRKR) · Health Care
Wolfe Research rates Bruker Corporation (BRKR) Peer Perform with a $60 price target, as of its latest action on Jun 2, 2026. It has published 4 rating actions on BRKR since December 2023, including 1 upgrade and 1 downgrade. Across 4 firms with a BRKR price target in the last 12 months, the median target is $62.50. Wolfe Research's $60 is 4% below that.
- Current rating
- Peer Perform
- Price target
- $60
- Median target, all firms
- $62.50
- Actions on BRKR
- 4
Wolfe Research price target on BRKR
Every Wolfe Research rating on BRKR
- Jun 2, 2026
- Dec 10, 2025
- Sep 30, 2024
- Dec 13, 2023
How other firms rate BRKR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Sector Perform | $66 | Nov 20, 2026 |
| UBS | Neutral | $65 | Sep 9, 2026 |
| Wolfe Research | Peer Perform | $60 | Jun 2, 2026 |
| Goldman Sachs | Sell | $40 | Dec 9, 2025 |
Questions about Wolfe Research and BRKR
- What is Wolfe Research's price target for BRKR?
- Wolfe Research's latest stated price target for Bruker Corporation (BRKR) is $60, from its action on Dec 10, 2025.
- What is Wolfe Research's rating on BRKR?
- Wolfe Research rates BRKR Peer Perform, a neutral rating, as of Jun 2, 2026.
- When did Wolfe Research last change its view on BRKR?
- On Jun 2, 2026, Wolfe Research resumes coverage at Peer Perform.
- How does Wolfe Research's BRKR target compare with other analysts?
- Across 4 firms with a BRKR price target in the last 12 months, the median target is $62.50. Wolfe Research's $60 is 4% below that.
More BRKR rating histories
All Wolfe Research ratingsBRKR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.